221 related articles for article (PubMed ID: 17991717)
21. The Relationships Between Loss of Standard CD44 Expression and Lymph Node, Liver Metastasis in T3 Colorectal Carcinoma.
Kunimura T; Yoshida T; Sugiyama T; Morohoshi T
J Gastrointest Cancer; 2009; 40(3-4):115-8. PubMed ID: 19937401
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.
Berner HS; Suo Z; Risberg B; Villman K; Karlsson MG; Nesland JM
Histopathology; 2003 Jun; 42(6):546-54. PubMed ID: 12786890
[TBL] [Abstract][Full Text] [Related]
23. Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation.
Khan SA; Cook AC; Kappil M; Günthert U; Chambers AF; Tuck AB; Denhardt DT
Clin Exp Metastasis; 2005; 22(8):663-73. PubMed ID: 16691370
[TBL] [Abstract][Full Text] [Related]
24. Metastatic potential of lymphoma/leukemia cell lines in SCID mice is closely related to expression of CD44.
Kawasaki N; Matsuo Y; Yoshino T; Yanai H; Oka T; Teramoto N; Liu C; Kondo E; Minowada J; Akagi T
Jpn J Cancer Res; 1996 Oct; 87(10):1070-7. PubMed ID: 8957066
[TBL] [Abstract][Full Text] [Related]
25. CD44 splice isoform switching determines breast cancer stem cell state.
Zhang H; Brown RL; Wei Y; Zhao P; Liu S; Liu X; Deng Y; Hu X; Zhang J; Gao XD; Kang Y; Mercurio AM; Goel HL; Cheng C
Genes Dev; 2019 Feb; 33(3-4):166-179. PubMed ID: 30692202
[TBL] [Abstract][Full Text] [Related]
26. Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer.
Zhang FL; Cao JL; Xie HY; Sun R; Yang LF; Shao ZM; Li DQ
Cancer Res; 2018 Oct; 78(20):5780-5792. PubMed ID: 30093560
[TBL] [Abstract][Full Text] [Related]
27. CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions.
Shirure VS; Liu T; Delgadillo LF; Cuckler CM; Tees DF; Benencia F; Goetz DJ; Burdick MM
Am J Physiol Cell Physiol; 2015 Jan; 308(1):C68-78. PubMed ID: 25339657
[TBL] [Abstract][Full Text] [Related]
28. Induction of tumor initiation is dependent on CD44s in c-Met⁺ hepatocellular carcinoma.
Dang H; Steinway SN; Ding W; Rountree CB
BMC Cancer; 2015 Mar; 15():161. PubMed ID: 25886575
[TBL] [Abstract][Full Text] [Related]
29. Standard CD44 modulates YAP1 through a positive feedback loop in hepatocellular carcinoma.
Fan Z; Xia H; Xu H; Ma J; Zhou S; Hou W; Tang Q; Gong Q; Nie Y; Bi F
Biomed Pharmacother; 2018 Jul; 103():147-156. PubMed ID: 29649630
[TBL] [Abstract][Full Text] [Related]
30. CD44s is a crucial ATG7 downstream regulator for stem-like property, invasion, and lung metastasis of human bladder cancer (BC) cells.
Zhu J; Huang G; Hua X; Li Y; Yan H; Che X; Tian Z; Liufu H; Huang C; Li J; Xu J; Dai W; Huang H; Huang C
Oncogene; 2019 Apr; 38(17):3301-3315. PubMed ID: 30635654
[TBL] [Abstract][Full Text] [Related]
31. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function.
Yu Q; Toole BP; Stamenkovic I
J Exp Med; 1997 Dec; 186(12):1985-96. PubMed ID: 9396767
[TBL] [Abstract][Full Text] [Related]
32. CD44 standard isoform is involved in maintenance of cancer stem cells of a hepatocellular carcinoma cell line.
Asai R; Tsuchiya H; Amisaki M; Makimoto K; Takenaga A; Sakabe T; Hoi S; Koyama S; Shiota G
Cancer Med; 2019 Feb; 8(2):773-782. PubMed ID: 30636370
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Impact of CD44 Expression in Patients With Myxofibrosarcoma.
Tsuchie H; Emori M; Miyakoshi N; Nagasawa H; Okada K; Nanjyo H; Murahashi Y; Mizushima E; Shimizu J; Yamashita T; Shimada Y
In Vivo; 2019; 33(6):2095-2102. PubMed ID: 31662543
[TBL] [Abstract][Full Text] [Related]
34. A novel Gemini vitamin D analog represses the expression of a stem cell marker CD44 in breast cancer.
So JY; Lee HJ; Smolarek AK; Paul S; Wang CX; Maehr H; Uskokovic M; Zheng X; Conney AH; Cai L; Liu F; Suh N
Mol Pharmacol; 2011 Mar; 79(3):360-7. PubMed ID: 21115634
[TBL] [Abstract][Full Text] [Related]
35. TGF-β2: A Novel Target of CD44-Promoted Breast Cancer Invasion.
Ouhtit A; Madani S; Gupta I; Shanmuganathan S; Abdraboh ME; Al-Riyami H; Al-Farsi YM; Raj MH
J Cancer; 2013; 4(7):566-72. PubMed ID: 23983821
[TBL] [Abstract][Full Text] [Related]
36. Inducible formation of leader cells driven by CD44 switching gives rise to collective invasion and metastases in luminal breast carcinomas.
Yang C; Cao M; Liu Y; He Y; Du Y; Zhang G; Gao F
Oncogene; 2019 Nov; 38(46):7113-7132. PubMed ID: 31417182
[TBL] [Abstract][Full Text] [Related]
37. CD44: structure, function, and association with the malignant process.
Naor D; Sionov RV; Ish-Shalom D
Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
[TBL] [Abstract][Full Text] [Related]
38. A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells.
Preca BT; Bajdak K; Mock K; Sundararajan V; Pfannstiel J; Maurer J; Wellner U; Hopt UT; Brummer T; Brabletz S; Brabletz T; Stemmler MP
Int J Cancer; 2015 Dec; 137(11):2566-77. PubMed ID: 26077342
[TBL] [Abstract][Full Text] [Related]
39. AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis.
Park J; Schlederer M; Schreiber M; Ice R; Merkel O; Bilban M; Hofbauer S; Kim S; Addison J; Zou J; Ji C; Bunting ST; Wang Z; Shoham M; Huang G; Bago-Horvath Z; Gibson LF; Rojanasakul Y; Remick S; Ivanov A; Pugacheva E; Bunting KD; Moriggl R; Kenner L; Tse W
Oncotarget; 2015 Aug; 6(24):20697-710. PubMed ID: 26079538
[TBL] [Abstract][Full Text] [Related]
40. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J
Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
